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The Health Care Cost Institute (HCCI) 
is pleased to present the 2014 Diabe-
tes Health Care Cost and Utilization 
Report, with a principal focus on 
trends in health care spending and 
utilization for the national population 
younger than age 65 and covered by 
employer-sponsored insurance (ESI) 
with diagnosed diabetes. In this re-
port, we also examine selected spend-
ing and utilization trends for the ESI 
population without diabetes (see box 
“Trends in Spending and Utilization of 
Health Care Services for People with-
out Diabetes”) and compare trends 
for the two populations – with and 
without diabetes – on selected spend-
ing and utilization measures. Howev-
er, unless specifically stated, the dis-
cussion in this report is for the popu-
lation with diabetes. 
This report covers the period 2012 to 
2014 (the “study period”), with the 
bulk of the analysis focused on 2014. 
Additionally, this report is a follow-up 
publication to Per Capita Health Care 
Spending on Diabetes: 2009-2013, 
which can be found on the HCCI Web-
site.1 Using the same general popula-
tion as the previous report on the ESI 
population with diabetes,2 this report 
details trends in total per capita 
spending, per capita out-of-pocket 
spending, and utilization of health 
care services. These spending and use 
trends were created at the national-
level and broken down by age group 
and gender. Additionally, we studied 
trends for two broad types of ser-
vices: medical (acute inpatient admis-
sions, outpatient services, and profes-
sional services) and prescription 
(brand and generic; see box “Service 
Categories Analyzed in this Report” 
for more information). 
The American Diabetes Association 
(ADA) estimated that for the entire 
population of Americans with diag-
nosed diabetes in 2012, per capita 
spending on health care was 
$13,741.3 For that year (the most re-
cent year that per capita health care 
spending estimates were available 
from the ADA), they found that per 
capita spending for people with dia-
betes was 3.9 times higher than 
spending for people without diabetes. 
This per capita figure for all Ameri-
cans with diabetes was about $1,000 
lower than the 2012 spending esti-
mate for our study population 
(younger than 65 with ESI) with dia-
betes presented  in this report 
($14,711). We found that in 2012, per 
capita spending for our study popula-
tion with diabetes was 3.56 times 
higher than spending for the study 
population without diabetes—a 
slightly lower figure than the ADA’s 
estimate. Much of the difference be-
tween HCCI’s and the ADA’s spending 
estimates is probably due to popula-
tion and methodological differences 
between the two samples.  
We estimated that between 2012 and 
2014, per capita spending for the in-
sureds with diabetes grew by $1,310 
(Table 1). Further, by 2014, per capita 
spending for this population was 3.64 
times higher than spending for the 
insureds without diabetes (Table 1 
and Appendix Table A2). In addition 
to per capita spending trends, our 
report examines per capita out-of-
pocket spending trends and the utili-
zation rates of health care service use 
for the insureds with diabetes. This 
Executive Summary 
$16,021 
 Health care spending per capita for 
people with diabetes 
 
$4,396 
 Health care spending per capita for 
people without diabetes 
 
12.1% 
 Share of total health care spending 
paid by out-of-pocket by individuals 
with diabetes 
 
17.1% 
 Share of total health care spending 
paid by out-of-pocket by individuals 
without diabetes 
 
1.2% and –1.0% 
 Changes in utilization of outpatient 
visits by people with and without dia-
betes 
 
9.6%  
 Share of total spending per capita for 
people with diabetes that was spent 
on antidiabetic agents 
BY THE  
NUMBERS: 2014 
www.healthcostinstitute.org  
2014 Diabetes Health Care Cost and Utilization Report  iii 
 
report proceeds in three sections: per 
capita spending trends, out-of-pocket 
spending trends, and utilization rates 
of health services. The findings from 
each of these sections and the similar-
ities and differences in trends be-
tween the insured populations with 
and without diabetes as well as high-
lights for a few notable spending and 
utilization trends observed in our 
study populations are briefly noted 
below.  
Spending and Utilization Trends for 
People with Diabetes in this Report 
In 2014, national per capita spending 
for insureds with diabetes grew 5.9% 
to $16,021, an increase of $897 over 
the previous year (Table 1). Per capita 
spending grew over the entire study 
period for all medical service catego-
ries, both men and women, and all age 
groups (see “HCCI Age Groups”). 
Spending on prescriptions grew at the 
fastest average annual rate over the 
study period (8.7%). The second fast-
est average annual growth was for 
outpatient services (5.0%), followed 
by professional services (2.2%), and 
acute inpatient care (2.2%). 
Over the study period, per capita 
spending was highest for pre-
Medicare adults (ages 55-64), fol-
lowed by children (ages 0-18), young 
adults (ages 19-25), and middle-age 
adults (ages 45-54); intermediate 
adults (ages 26-44) had the lowest 
spending.  
Corresponding to the increase in total 
per capita spending were increases 
over the study period in per capita 
out-of-pocket spending for insureds 
with diabetes. In 2014, per capita out-
of-pocket spending was $1,944, a $10 
increase over the previous year 
(Table 2). In each year of the study 
period, per capita out-of-pocket 
spending on each of the medical ser-
vice categories increased. At the 
same, there were declines in the out-
of-pocket spending on prescriptions. 
This decline in prescription spending 
out of pocket was most pronounced 
for the oldest age group. Per capita 
out-of-pocket spending by pre-
Medicare adults fell between 2013 
and 2014, due to a decline in their out
-of-pocket spending on prescriptions, 
specifically brand prescriptions. In 
2012 and 2013, pre-Medicare adults 
had the highest out-of-pocket spend-
ing of all of the age groups studied. 
However, due to the decline in this 
spending between 2013 and 2014, the 
highest out-of-pocket spending per 
capita in 2014 was for children. 
In contrast to the year-on-year in-
crease in spending per capita ob-
served over the study period, the uti-
lization of medical services and brand 
prescriptions generally declined 
(Table 3). Small increases in the rates 
of use of outpatient visits and generic 
prescriptions occurred in every year 
studied. The increase in use of generic 
prescriptions more than offset the 
decline in the use of brand prescrip-
tions, leading to a net increase in total 
prescription use (brand prescriptions 
plus generic prescriptions) each year 
of the study period. In 2014, there 
were 1,242,571 filled days of pre-
scriptions per 1,000 people with dia-
betes. This prescription use rate aver-
ages to just over 3 filled days of pre-
scriptions per person with diabetes 
per day. 
Comparison of Trends for People 
with and Without Diabetes 
In 2014, total per capita spending for 
the study population with diabetes 
was 3.6 times higher than spending 
for those without diabetes (Table 1 
and Appendix Table A2). Out-of-
pocket per capita spending was 2.6 
times higher for people with diabetes 
than for those without (Table 2 and 
Appendix Table A19). Compared to 
people without diabetes, utilization of 
services by people with diabetes 
ranged from 2.4 times higher use of 
outpatient visits to 7.1 times higher 
use of brand prescriptions (Table 3 
and Appendix Table A36).  
The per capita spending trends for 
people with diabetes generally looked 
quite different from the spending 
trends for people without diabetes 
(Table 1 and Appendix Table A2). For 
children without diabetes, spending 
per capita was the lowest of any age 
group without diabetes studied 
($2,613 in 2014). In comparison, 
spending for children with diabetes 
was the second highest for any age 
group with diabetes ($17,380 in 
2014). This trend was similar for 
young adults. Young adults without 
diabetes had the second-lowest 
spending per capita of any age group 
without diabetes ($2,664), while 
young adults with diabetes had the 
third-highest spending of any age 
group with diabetes ($15,839). Over-
all, for those without diabetes, the 
younger age groups had low spending 
compared to the older age groups, 
while the opposite tended to be true 
for the younger age groups with dia-
HCCI AGE GROUPS 
Children 
Ages 0 through 18. 
Young Adults  
Ages 19 through 25. 
Intermediate Adults  
Ages 26 through 44. 
Middle-Age Adults  
Ages 45 through 54. 
Pre-Medicare Adults  
Ages 55 through 64. 
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betes. This trend for the younger age 
groups was more pronounced for out-
of-pocket per capita spending (Table 
2 and Appendix Table A19). In 2014, 
out-of-pocket per capita spending for 
children with diabetes was highest of 
the five age groups ($2,173), while 
lowest for children without diabetes 
($466). 
Shares of total per capita spending by 
categories of services also differed 
between the two populations. For 
people with diabetes, the share of 
total spending for each service cate-
gory ranged between 24% and 26%, a 
fairly even spending distribution 
across types of services (Table 1). In 
contrast, per capita spending for peo-
ple without diabetes was highest for 
professional services (35.4% of their 
total spending) and lowest for pre-
scriptions (16.9%; Appendix Table 
A2). For out-of-pocket per capita 
spending, the out-of-pocket dollars 
spent on acute admissions and outpa-
tient visits were quite similar across 
the two populations (Table 2 and Ap-
pendix Table A19). People with diabe-
tes spent 6.6% of their out-of-pocket 
dollars on acute admissions and 
25.7% on outpatient services, while 
people without diabetes spent 6.1% 
and 28.5% of their out-of-pocket dol-
lars on those services.  
However, people with diabetes spent 
proportionally more out-of-pocket on 
prescription services per capita 
(32.4%) compared to people without 
diabetes (18.9%; Table 2 and Appen-
dix Table A19). At same time, people 
without diabetes spent proportionally 
more out of pocket on professional 
services (46.4% of their out-of-pocket 
spending) compared to people with 
diabetes (35.2%). The largest differ-
ence in per capita spending and out-of
-pocket spending between the two 
populations was for prescriptions. 
The largest component of this pre-
scription spending difference was due 
to antidiabetic agents. In 2014, for 
people with diabetes, per capita 
spending on antidiabetic agents 
(brand and generic agents) was 
$1,531, with $182 of that spent out of 
pocket (Appendix Tables A3 and 
A20), compared to per capita spend-
ing for people without diabetes of $6, 
with $1 spent out of pocket (Appendix 
Tables A4 and A21). Higher total 
spending and out-of-pocket spending 
on cardiovascular agents and central 
nervous system (CNS) agents for peo-
ple with diabetes were also observed. 
For people with diabetes, spending 
per capita was 7.7 times higher on 
cardiovascular drugs and 2.4 times 
higher on CNS agents than spending 
for people without diabetes. The rates 
of use of these prescriptions help ex-
plain these spending trends. People 
with diabetes used 7.5 times more 
filled days of cardiovascular drugs 
and 2.6 times more CNS agents than 
people without diabetes (Appendix 
Tables A37 and A38). 
Notable Trends 
Use of antidiabetic agents: For chil-
dren and young adults with diabetes, 
the most commonly used prescription 
class was brand antidiabetic agents 
(Appendix Tables A43 and A45; see 
“Service Categories Analyzed in this 
Report”). This class includes medica-
tions commonly taken to manage 
blood glucose levels in people with 
diabetes, including, insulin, metfor-
SERVICE CATEGORIES ANALYZED IN THIS REPORT 
In this report, HCCI analyzed medical and prescription claims for individuals (ages 0–64) covered by ESI. As in prior 
reports, HCCI grouped these claims into distinct service categories for analytic purposes. See the 2014 HCCI Analytic 
Methodology for a detailed description of HCCI’s claims categorization methods.5 
Medical service, subservice, and detailed service categories in this report 
Three medical service categories were identified: inpatient facility, outpatient facility, and professional procedures. 
These categories divide into three medical subservice categories: acute inpatient admissions, which included labor 
and delivery (LD), medical, mental health and substance use (MH/SU), newborn, and surgery admissions; outpatient 
visits; and outpatient other services. These further divide into “detailed service” categories.5  
Prescription service, subservice, detailed service categories, and therapeutic subclasses in this report 
HCCI analyzed prescription claims from retail and mail order pharmacies. The prescription service category divides 
into brand and generic subservice categories. These subservices further divide into “detailed service” categories, 
which divide into therapeutic subclasses .3 (See the methodology document for more details.) In this report, HCCI also 
examined two therapeutic subclasses of prescriptions – as defined by the American Hospital Formulary Service 
(AHFS) – antidiabetic agents and contraceptives .5,6 
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min, and oral hypoglycemics.4 In 
2014, there were 255,481 filled days 
of brand antidiabetic agents per 1,000 
children and 172,369 filled days per 
1,000 young adults. For the three old-
est age groups, use of generic antidia-
betic agents was more common than 
use of brand antidiabetic agents 
(Appendix Tables A47, A49, A51). For 
example, for intermediate adults, 
there were 96,730 filled days of brand 
antidiabetic agents per 1,000 adults 
and 116,843 filled days of generic 
antidiabetics per 1,000. 
Use of generic cardiovascular drugs by 
oldest adults: For the three oldest age 
groups (intermediate adults, middle-
age adults, and pre-Medicare adults), 
the most commonly used prescription 
class was generic cardiovascular 
agents (Appendix Tables A47, A49, 
A51). For middle-age adults and pre-
Medicare adults, the second-most 
used prescription class was generic 
antidiabetic agents. However, for in-
termediate adults, the second-most 
used prescription class was generic 
central nervous system (CNS) agents.   
LD hospital admissions: For the study 
population without diabetes, the use 
rate of labor and delivery (LD) hospi-
tal admissions increased with age 
over the first three age groups 
(children, young adults, and interme-
diate adults; Exhibit 1). In 2014, in the 
population without diabetes, there 
was 1 LD admission per 1,000 chil-
dren without diabetes (Appendix Ta-
ble A43), 18 LD admissions per 1,000 
young adults without diabetes 
(Appendix Table A45), and 32 LD ad-
missions per 1,000 intermediate 
adults without diabetes (Appendix 
Table A47). For intermediate adults, 
there were more LD admissions per 
1,000 adults for the population with-
out diabetes (32) than for the popula-
tion with diabetes (25). However, this 
pattern is reversed for young adults. 
For young adults with diabetes, there 
was a higher use rate of LD (28 ad-
missions per 1,000) than for the pop-
ulation of young adults without diabe-
tes (18 admissions per 1,000) or for 
Exhibit 1: Utilization of Labor and Delivery Hospital Admissions by 
Children, Young Adults, and Intermediate Adults with and without 
Diabetes (2014) 
 
Source: HCCI 2016. 
  Labor and Delivery Admissions per 1,000 Insureds in 2014 
Age Group With Diabetes Without Diabetes 
Children (ages 0-18) 1 1 
Young Adults (ages 19-25) 28 18 
Intermediate Adults (ages 26-44) 25 32 
THE PREVALENCE OF DIAGNOSED DIABETES IN THE HCCI POPULATION 
In 2014, we identified 5.0% of the individuals younger than age 65 and covered by ESI as having diagnosed diabetes. From 
2012 to 2014, the percentage of those with diabetes remained constant at 5.0% (Appendix Table A1).  
The percentage of insureds with diabetes in 2012 and 2013 identified in this report is now slightly lower than the population 
HCCI reported in Per Capita Health Care Spending on Diabetes: 2009-2013.1 In that prior report, 5.3% of insureds were identi-
fied as having diagnosed diabetes in both years. This downward adjustment in the membership trend of insureds identified 
as having diagnosed diabetes (about 0.3%) was the result of changes made to the analytic methodology and the diabetes 
flag.5 
The newly reported number for 2012 and 2013 is closer to other estimates of the prevalence of diabetes among the privately 
insured population. For instance, the ADA estimated a rate of 4.6% in 2012 for the privately insured population.3 This small 
difference in prevalence rates (0.4%) may be attributable to differences in population and study methodology. 
In this report, we also identified 6.6% of all adults and 0.3% of all children in the dataset as having diagnosed diabetes. The 
percentage of adults and children with diabetes remained constant over the study period.  
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the intermediate adults with diabetes 
(25 admissions per 1,000). We do not 
have an explanation for these differ-
ences.    
MH/SU hospital admissions for young 
adults: In 2014, there were 37 mental 
health and substance use (MH/SU) 
hospital admissions per 1,000 young 
adults with diabetes (Appendix Table 
A45). This this use rate increased 
from 22 MH/SU admits per 1,000 in 
2012, a 68.2% increase. MH/SU ad-
missions had the second highest use 
rate of any type of admission for 
young adults. Comparatively, this was 
the highest rate of MH/SU use of any 
age group studied. The next highest 
rate of MH/SU use was for children, 
who had 21 MH/SU admissions per 
1,000 children with diabetes 
(Appendix Table A43). And for chil-
dren, these admissions increased 
23.5% over the study period.  
Spending and use trends for children: 
Compared to most of the other age 
groups, children had high per capita 
spending, high out-of-pocket spend-
ing, and high rates of use of health 
services (Tables 2 and 3, Appendix 
Table A41). In all years studied, chil-
dren had the second highest spending 
per capita; the highest out-of-pocket 
spending per capita in the last year of 
the study period (2014); the highest 
rate of use of outpatient services, spe-
cifically outpatient-other services; 
and, after young adults, the second-
highest use rate of acute hospital ad-
missions, specifically medical hospital 
admissions (195 acute admissions per 
1,000 children in 2014). 
TRENDS IN SPENDING AND UTILIZATION OF HEALTH CARE SERVICES FOR PEOPLE WITHOUT DIABETES 
During the study period (2012-2014), per capita spending for people without diagnosed diabetes was over $10,000 lower 
than per capita spending for people with diagnosed diabetes (Table 1 and Appendix Table A2). For example, in 2014, spend-
ing for people without diabetes was $4,396 per capita, while spending for people with diabetes was $16,021 per capita. In all 
years studied, spending for those without diabetes was about one quarter of the spending for people with diabetes. This dif-
ference in spending was due largely to much lower rates of utilization of services by people without diabetes as compared to 
the service use of people with diabetes.  
For people without diabetes, per capita spending between 2012 and 2014 increased from $4,138 to $4,396 (Appendix Table 
A2). During this period, spending grew about 3% per year. In 2014, the largest share of per capita spending for people with-
out diabetes (35.4%) was on professional services ($1,556). Per capita spending on outpatient services was 28.5% of total 
spending in 2014 ($1,255). Of that per capita amount on outpatient services, 63.7% was on outpatient visits ($799), while 
the rest was spending on outpatient-other services ($456). Per capita spending on acute inpatient services accounted for 
18.9% of total spending ($832), leaving 16.9% of spending on prescriptions. Of the $745 per capita spent on prescriptions in 
2014, $264 was spent on generic prescriptions, while $481 was spent on brand prescriptions. 
In 2014, out-of-pocket spending per capita for people without diabetes was $752 (Appendix Table A19), increasing by $43 
per person over the study years. The largest share of out-of-pocket spending (46.4%) was on professional services ($349 per 
capita). Out-of-pocket spending on prescriptions ($142 per capita) and outpatient services ($214 per capita) accounted for 
18.9% and 28.5% of total out-of-pocket spending, respectively. The smallest share of out-of-pocket spending (6.1%) was on 
acute inpatient services ($46 per capita).  
Between 2012 and 2014, for people without diabetes, the use of acute inpatient services, outpatient services, and brand pre-
scriptions declined each year. During that period, the number of acute inpatient admissions declined from 50 per 1,000 peo-
ple without diabetes in 2012 to 47 in 2014 (Appendix Table A36). Similarly, the use of outpatient services declined by about 
1.5% per year. This decline was observed for both outpatient visits (a 8 visit per 1,000 person decline) and outpatient-other 
services (a 66 services per 1,000 person decline). The largest declines in use were for brand prescriptions, for which the 
number of filled days per 1,000 people declined by more than 15% per year during the study period – from 44,287 filled days 
per 1,000 people without diabetes in 2012 to 30,361 filled days in 2014. Use of professional services rose slightly between 
2012 and 2013 (by 57 services per 1,000 people). The following year, use of these services declined by 175 services to 
15,152 professional services per 1,000 people without diabetes. Only use of generic prescriptions increased during the study 
period: use of generic prescriptions increased from 189,305 filled days per 1,000 people to 202,808 filled days.   
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In 2014, total per capita spending 
(payer spending plus out-of-pocket 
spending) was $16,021 on health care 
for insureds under 65 with diagnosed 
diabetes (Table 1). Over the study 
period (2012-2014), per capita 
spending increased every year, rising 
at average annual rate of 4.3%. 
Spending per capita increased from 
2012 to 2013 by $413 and from 2013 
to 2014 by an additional $897.  
Proportionally, per capita spending 
for insureds with diabetes was dis-
tributed fairly evenly across the ma-
jor service categories (see “Service 
Categories Analyzed in this Report”). 
Of total per capita spending in 2014, 
the largest share, 26.0%, was on out-
patient care (Table 1 and Figure 1). 
The remaining shares were split 
across acute inpatient admissions 
(24.8% of total spending), prescrip-
tions (24.8%), and professional ser-
vices (24.0%).  
For each of the service categories, per 
capita spending rose every year of the 
study period. Spending on prescrip-
tions grew at the fastest average an-
nual rate over the study period 
(8.7%), followed by growth in spend-
ing for outpatient services (5.0%), 
professional services (2.2%), and 
acute inpatient care (2.2%). 
Outpatient Spending 
Per capita spending for the study pop-
ulation with diabetes was higher on 
outpatient services than on any other 
service category. In 2014, per capita 
spending on outpatient services was 
$4,172 (Table 1). The majority of 
spending on outpatient services was 
on outpatient visits. For example, in 
2014, per capita spending for in-
sureds with diabetes was $2,254 on 
outpatient visits, compared with 
spending on outpatient-other ser-
vices, at $1,918. 
In 2014, outpatient visits accounted 
for 54.0% of spending on outpatient 
services (Table 1). Per capita spend-
ing on outpatient visits grew from 
2012 to 2013 by $102, and from 2013 
to 2014 by an additional $157 (Table 
1). Of the dollars spent on outpatient 
visits in 2014, insureds with diabetes 
spent the most on outpatient surgery 
($1,396), followed by emergency 
room (ER) visits ($715), and observa-
tion visits ($143; Appendix Table A3). 
The fastest growth rate in spending 
during the study period among outpa-
tient visits was for ER visits, which 
grew at an average annual rate of 
10.0% (a $123 increase).  
The remaining 46.0% of per capita 
spending on outpatient services was 
on outpatient-other services ($1,918; 
Table 1). From 2012 to 2013, per cap-
ita spending on outpatient-other ser-
vices increased by $62 and then grew 
from 2013 to 2014 by an additional 
$63. Of total spending per capita on 
outpatient-other services, the largest 
per capita amount was for miscellane-
Spending Per Capita for Insureds with Diabetes 
For people with diabetes, spending per capita on outpatient an-
cillary services was 6.5 times higher than for people without dia-
betes (Appendix Tables A3 and A4). 
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ous services ($820; Appendix Table 
A3). This was followed by spending 
on radiology services ($475), ancil-
lary services ($417), and laboratory 
and pathology services ($207).  
Acute Inpatient Spending  
In 2014, per capita spending for 
individuals with diabetes was $3,975 
on acute inpatient services (Table 1). 
From 2012 to 2013, per capita spend-
ing on acute inpatient admissions in-
creased by $51 dollars – the smallest 
increase for a service category that 
year. From 2013 to 2014, spending on 
acute inpatient admissions increased 
by an additional $121. Of the total 
dollars per capita spent in 2014 on 
acute inpatient admissions, the larg-
est share was on surgical admissions 
(57.5%, $2,287 per capita) (Appendix 
Table A3). Most of the rest that 
spending was on medical admissions 
(39.6%), $1,575 per capita.    
Professional Services Spending  
In 2014, per capita spending on pro-
fessional services was $3,832 (Table 
1). This was the service category with 
the lowest per capita spending, alt-
hough spending on professional ser-
vices was just $340 per capita lower 
than on the highest spending service 
category (outpatient services). From 
2012 to 2013, per capita spending on 
professional services increased by 
$85, and from 2013 to 2014, grew by 
an additional $76. This growth in 
2014 was the smallest increase in 
spending observed for any category in 
that year. Of the total spending in 
2014 on professional services, the 
largest amount was on miscellaneous 
services ($982), followed by surgical 
professional services ($655), and ad-
ministered drugs ($555; Appendix 
Table A3).  
Prescription Spending  
In 2014, per capita spending on all 
prescriptions was $3,970 (Table 1). 
Spending on prescriptions grew at the 
fastest average annual rate of any 
service category during the study pe-
riod (8.7%). Of the per capita spend-
ing on prescriptions in 2014, 71.1% 
was on brand prescriptions and 
28.6% was on generic prescriptions.7 
From 2012 to 2013, per capita spend-
ing on brand prescriptions grew by 
$77 and from 2013 to 2014, grew by 
an additional $395. Over the study 
period, spending on generic prescrip-
tions increased by a smaller amount 
than did spending on brand prescrip-
tions. Between 2012 and 2014, 
spending on generic prescriptions 
increased by $125. 
In 2014, spending on brand prescrip-
tions was $2,829 per capita (Tables 
1). Of that amount, 50.0% was for 
brand antidiabetic agents ($1,412; 
Appendix Table A3). Between 2012 
and 2013, spending on brand antidia-
betic agents grew by $88, and by ad-
ditional $272 the following year. Both 
of these increases were the largest 
increases for detailed classes of brand 
prescriptions in their respective 
years. The next highest spending on a 
detailed class of brand prescriptions 
was on cardiovascular drugs ($276), 
just 9.8% of brand spending.8 Spend-
ing on brand anti-infective agents was 
the third highest spending detailed 
class of brand prescriptions in 2014 
($206). Spending on these prescrip-
tions also rose over the study period – 
from 2012 to 2013, by just $1, and by 
$99 from 2013 to 2014.  
Spending on generic prescriptions 
was $1,138 in 2014 (Table 1). Of that 
amount, the most dollars were spent 
on cardiovascular drugs ($238) and 
central nervous system (CNS) agents 
($215; Appendix Table A3). Generic 
antidiabetic agents made up just 
10.5% of total spending on generic 
prescriptions ($119), and fell by $19 
from the previous year. Between 
2013 and 2014, spending on generic 
prescriptions increased by $87. The 
biggest contributor to this growth 
was an increase in spending on gener-
ic CNS agents, which rose $36 dollars.  
Per Capita Spending by Gender 
Women with diabetes had higher 
spending per capita than men with 
diabetes in every year of the study 
period. For example, in 2014, per cap-
ita spending for women was $16,409, 
compared with $15,688 for men 
(Table 1). The difference between per 
capita spending for men and women 
narrowed over the study period—
from $951 to $721. This reduction in 
the spending difference between men 
and women was due to a larger in-
crease in spending over the study pe-
riod for men ($1,420) than for women 
($1,190).   
In 2014, per capita spending on acute 
inpatient admissions and prescrip-
tions for men was $376 higher than 
For people without diabetes, spending on professional services 
made up 35.4% of their total per capita health care spending, 
while it made up just 23.9% of the spending for people with dia-
betes (Table 1 and Appendix Table A2). 
Per capita spending on mental health and substance use admis-
sions was over 4.5 times higher for people with diabetes than for 
those without diabetes (Appendix Tables A3 and A4). 
www.healthcostinstitute.org  
2014 Diabetes Health Care Cost and Utilization Report  3 
 
 
SHARE OF PER CAPITA SPENDING ON MEDICAL SERVICE CATEGORIES FOR INSUREDS WITH AND WITHOUT 
DIABETES  
Compared to individuals with diagnosed diabetes, per capita spending for people that were not diagnosed with diabetes was 
much lower. Spending for people without diabetes in 2014 was $4,396 per capita (Appendix Table A2), compared to $16,021 
per capita for people with diabetes (Table 1 and Figure 2). The distribution of per capita spending across health care service 
categories was different for the populations with and without diabetes.  
The largest share of the total per capita spending for individuals without diagnosed diabetes in 2014 was on professional 
services (35.4%, $1,556 per capita; Appendix Table A2). Comparatively, for those with diagnosed diabetes, professional ser-
vices accounted for the smallest share of their spending per capita (24.0% or $3,832; Table 1). For both populations, the 
shares of spending on professional services were distributed similarly across the professional services detailed categories. 
However, we observed a difference in the share of dollars spent on visits to the doctor. For people with diabetes, 18.4% 
($705) of their per capita spending on professional services was on visits to the doctor, compared to 22.0% ($342) for those 
without diabetes (Appendix Tables A3 and A4).  
The largest share of spending for people with diabetes was on outpatient services (26.0%, $4,172 per capita), while outpa-
tient services was the second highest-spending share for people without diabetes (28.5%, $1,255 per capita); Table 1 and 
Appendix Table A2). People with diabetes spent a smaller share of their outpatient dollars on outpatient surgery and emer-
gency room visits than people without diabetes. Those with diabetes spent 50.6% of their outpatient dollars on emergency 
room visits and outpatient surgery. Comparatively, those without diabetes spent a larger share, 60.8% on emergency room 
visits and outpatient surgery (Appendix Tables A3 and A4). People without diabetes had a larger share of their outpatient 
spending on outpatient surgery, while those with diabetes had higher spending in terms of dollars per capita on outpatient 
surgery ($1,396) compared to people without diabetes ($480). 
$14,711 $15,124
$16,021
$4,138 $4,262 $4,396
2.7% 2.8%
5.9%
3.3%
3.0% 3.2%
2012 2013 2014
 
Diabetes
No Diabetes
Source: HCCI, 2016.
Notes: All data weighted to reflect the national, younger than 65 ESI population.
Data from 2013 and 2014 adjusted using actuarial completion.
Spending Per Capita and Change in Spending for 
Insureds With and Without Diabetes: 2012-2014
Figure 2
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for women. (Appendix Table A5). Ad-
ditionally, spending on inpatient ad-
missions for men accounted for the 
largest share of spending for men 
(26.4%, or $4,149 per man) but the 
smallest share of spending for women 
(23%, or $3,773 per woman). Per cap-
ita spending for men on prescriptions 
was $142 higher than prescription 
spending for women. This higher 
spending for men was due to higher 
spending on brand prescriptions. In 
2014, spending on brand prescrip-
tions was $2,953 per man compared 
to $2,686 per woman. However, 
spending for women on generic pre-
scriptions ($1,205) was higher than 
for men ($1,081).  
In 2014, per capita spending for wom-
en was higher than for men, largely 
due to higher spending on outpatient 
services ($417 more for women) and 
professional services ($808 more for 
women; Appendix Table A5). For 
women, the highest spending catego-
ries of health care services was on 
outpatient services and professional 
services. Outpatient services repre-
sented 26.8%, or $4,396, of per capita 
spending for women, while profes-
sional services made up 26.0%, or 
$4,226, of their spending.  
Per Capita Spending by Age Group 
Over the study period, per capita 
spending was highest for pre-
Medicare adults (ages 55-64) fol-
lowed by children (ages 0-18), young 
adults (ages 19-25), and middle-age 
adults (ages 45-54); intermediate 
adults (ages 26-44) had the lowest 
spending (Table 1). 
Children 
Children had the second highest per 
capita spending in 2014 ($17,380), 
which was $462 per capita lower than 
spending for pre-Medicare adults 
(Table 1). Over the study period, per 
capita spending for children in-
creased by a larger amount than did 
spending for pre-Medicare adults: a 
$2,337 increase for children and a 
$1,374 increase for pre-Medicare 
adults. From 2012 to 2013, per capita 
spending for children grew by $1,158, 
and from 2013 to 2014, grew by an 
additional $1,179. The largest amount 
for children was spent on prescrip-
tions ($6,286 per child; Appendix Ta-
ble A 7 and Figure 3). This spending 
on prescriptions was higher than for 
any other age group. Spending per 
capita for children on prescriptions 
was $1,866 per capita higher than for 
pre-Medicare adults, the next highest 
spending age group. Of the amount 
per capita for children, most was on 
brand antidiabetic agents: $3,301 per 
child in 2014.  
Conversely, compared to the other 
age groups in 2014, children had the 
lowest per capita spending on profes-
sional services ($2,771; Appendix 
Table A7 and Figure 3). The most pro-
fessional dollars were spent on visits 
to the doctor ($834 per child) and 
professional surgical services ($194 
per child; Appendix Table A9). Chil-
dren also had the lowest spending of 
any age group on outpatient visits 
($1,350 per child). Of this amount, 
57.4% was on ER visits ($775 per 
child) and 33.7% were on outpatient 
surgical visits ($455 per child). 
Young Adults 
In 2014, per capita spending for 
young adults was $15,839 (Table 1). 
Between 2012 and 2013, spending for 
young adults increased by $517 per 
capita. The following year, spending 
for young adults increased by an addi-
tional $1,563. This growth was the 
largest increase in spending observed 
for that year for any age group. The 
largest portion of the per capita 
spending for young adults was on 
acute inpatient admissions, as was 
also true for pre-Medicare adults 
(Figure 3). In 2014, young adults had 
the highest spending per capita on 
acute admissions ($4,608 per young 
adult) of any age group (Appendix 
Table A7). For young adults, the high-
est spending for acute admissions in 
2014 was on medical admissions 
($2,734 per capita), followed by surgi-
cal admissions ($1,217), labor and 
deliver (LD) admissions ($305), and 
mental health and substance use 
(MH/SU) admissions ($352; Appendix 
Table A11).  
The second highest spending for 
young adults was on prescriptions 
($4,074; Appendix Table A7 and Fig-
ure 3). Of this amount, nearly 60% 
was on brand antidiabetic agents 
($2,332 per capita; Appendix Table 
A11). While spending per capita on 
outpatient services was comparative-
ly lower than spending on acute ad-
missions and prescriptions, a compar-
atively high amount was spent per 
capita on two types of outpatient ser-
vices (Appendix Table A7). For young 
adults, $1,253 was spent per capita on 
ER visits and $1,143 was spent on 
ancillary services (Appendix Table 
A11).  
Intermediate Adults 
In 2014, intermediate adults had the 
lowest per capita spending of all of 
the age groups: $13,141 (Table 1). 
Similar to middle-age adults, interme-
diate adults spent the most on outpa-
tient services ($3,670 per capita; Ap-
pendix Table A7 and Figure 3). Outpa-
tient surgical visits ($1,005 per capi-
ta) and ER visits ($971 per capita) 
accounted for the most of these 
adults’ spending on outpatient ser-
vices (Appendix Table A13). Interest-
ingly, intermediate adults had the 
lowest spending of any age group on 
outpatient-other services. One factor 
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driving this was the comparatively 
low per capita spending on outpatient 
lab/path services ($178 per interme-
diate adult). 
The second most per capita spending 
for intermediate adults was on pro-
fessional services ($3,259), followed 
by acute inpatient admissions 
($3,127; Appendix Table A7). The 
most acute inpatient dollars were 
spent on surgical admissions ($1,468 
per capita) followed by medical ad-
missions ($1,308; Appendix Table 
A13). Compared to spending for inter-
mediate adults, spending for young 
adults on LD admissions and MH/SU 
admissions was 11.3% and 363.0% 
higher, respectively (Appendix Tables 
A11 and A13). 
The lowest spending per capita was 
on prescriptions ($3,060; Appendix 
Table A7). The intermediate adult 
group was the only age group for 
which prescriptions was the lowest 
spending service category. Compared 
to the other age groups, spending for 
intermediate adults on brand antidia-
betic agents (the prescription class 
with the highest per capita spending 
for every age group) was lower 
($1,286 per intermediate adult; Ap-
pendix Table A13). 
Middle-Age Adults 
In 2014, per capita spending for mid-
dle-age adults ($14,755) was the sec-
ond lowest of any age group (Table 
1). Middle-age adults also had the 
lowest per capita spending increase 
($1,145) over the study period. Be-
tween 2012 and 2013, per capita 
spending for these adults grew by 
$397, and spending grew by an addi-
tional $748 the following year. As 
with intermediate adults, for middle-
age adults, the service category with 
the highest spending in 2014 was out-
patient services ($3,951 per capita; 
Appendix Table A7 and Figure 3). 
Within outpatient services, the high-
est per capita spending was on outpa-
tient surgical services ($1,323) and 
ER visits ($734; Appendix Table A15). 
Compared to the other age groups, 
middle-age adults had the lowest per 
capita spending on ancillary services 
($349), a comparatively higher 
spending category for children 
($1,932; Appendix Table A9) and 
young adults ($1,143; Appendix Table 
A11).  
Middle-age adults were the only age 
group where acute inpatient admis-
sions was the lowest spending catego-
ry of services ($3,492 per capita; Ap-
pendix Table A7 and Figure 3). One 
factor driving this appears to be the 
comparatively low spending on medi-
cal admissions ($1,364 per capita) 
compared to the other age groups 
(Appendix Table A15). 
Pre-Medicare  Adults 
As with pre-Medicare adults general-
ly,9 pre-Medicare adults with diabetes 
had the highest per capita spending in 
every year of the study period. In 
2014, per capita spending for pre-
Medicare adults was $17,842 (Table 
1). From 2012 to 2013, spending for 
pre-Medicare adults rose $429 per 
capita; from 2013 to 2014, spending 
increased by an additional $945. Of 
the total per capita spending for pre-
Medicare adults in 2014, the largest 
amount was spent on acute inpatient 
admissions ($4,563; Appendix Table 
A7 and Figure 3). Pre-Medicare adults 
and young adults were the only two 
age groups that had higher spending 
on acute admissions than any other 
service category. Pre-Medicare adults 
also had the highest per capita spend-
ing on surgical admissions of any age 
group ($2,799; Appendix Table A17). 
Interestingly, this group had the low-
est per capita spending on MH/SU 
admissions ($35). After acute admis-
sions, for pre-Medicare adults, the 
second largest amount per capita was 
spent on outpatient services ($4,501), 
followed by prescriptions ($4,420), 
and professional services ($4,251; 
Appendix Table A7).  
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Out-of-Pocket Spending Per Capita for Insureds with 
Diabetes 
In 2014, people with diabetes spent 
$1,944 out of pocket per capita (Table 
2). Of total per capita spending on health 
care in 2014 ($16,021), 12.1% was 
spent out of pocket by people with dia-
betes. Overall, per capita out-of-pocket 
spending grew more from 2012 to 2013 
($66, or 3.6%) than it did from 2013 to 
2014 ($10, or 0.5%; Figure 4). This is 
opposite of the trend for total per capita 
spending, which rose more between 
2013 and 2014 than between 2012 and 
2013.  
Of the per capita out-of-pocket dollars 
spent in 2014, insureds with diabetes 
spent the most on professional services 
($684; Table 2). After professional ser-
vices, out-of-pocket spending per capita 
was highest on prescriptions ($629), 
followed by spending on outpatient ser-
vices ($500). The smallest amount of per 
capita out-of-pocket spending was on 
acute inpatient services ($128). The 
overall increase in out-of-pocket spend-
ing per capita was smaller from 2013 to 
2014 than from 2012 to 2013. The 
smaller increase was due largely to de-
clining per capita out-of-pocket spend-
ing on prescriptions and acute inpatient 
admissions, which offset increasing out-
of-pocket spending on outpatient ser-
vices. Per capita spending out-of-pocket 
on prescriptions declined both years of 
the study period, first by 8.9%, or $22, 
from 2012 to 2013, and then by an addi-
tional 6.8%, or $37 from 2013 to 2014. 
Out-of-pocket spending per capita on 
acute inpatient admissions rose by $9 
dollars from 2012 to 2013, but fell by $6 
from 2013 to 2014.  
Overall, total out-of-pocket spending 
rose in all years studied (Table 2). The 
increases in out-of-pocket spending 
were due largely to increases in per cap-
ita spending on outpatient and profes-
sional services. The increase in out-of-
pocket spending was larger for outpa-
tient services than for professional ser-
vices. Out-of-pocket per capita spending 
on outpatient services rose by $40 from 
2012 to 2013, and then grew by an addi-
tional $34 from 2013 to 2014.  Out-of-
pocket per capita spending on profes-
sional services also rose during the 
study period, growing by $41 from 2012 
to 2013, and by an additional $19 from 
2013 to 2014.  
Professional Services Out-of-Pocket 
In 2014, among the service categories, 
out-of-pocket spending per capita was 
highest for professional services ($684; 
Table 2). Of the out-of-pocket spending 
on professional services in 2014, the 
largest share (31.7%) was spent on doc-
tor visits ($201 per capita; Appendix 
Table A20). This was followed by out-of-
pocket spending on professional surgi-
cal services ($90 per capita) and profes-
sional laboratory and pathology (lab/
path) services ($85 per capita).  
Between 2012 and 2013, out-of-pocket 
spending on doctor visits rose from 
$201 to $217 (Appendix Table A20). 
Between 2013 and 2014, however, there 
was no increase in out-of-pocket per 
capita spending on doctor visits. This 
flat growth led to a smaller increase in 
total out-of-pocket spending on all pro-
fessional services in 2014 ($19) than 
occurred in the previous year ($41; Ta-
ble 2).  
Prescriptions Out-of-Pocket 
From 2012 to 2013, per capita out-of-
pocket spending on prescriptions fell by 
$22 dollars, and fell by an additional $37 
dollars between 2013 and 2014 (Table 
2). In 2014, out-of-pocket spending on 
all prescriptions was $629 per capita. Of 
that amount, $297 was spent on brand 
prescriptions and $331 was spent on 
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generic prescriptions. Brand prescrip-
tion out-of-pocket spending per capi-
ta declined each year studied, leading 
to the decline in total prescription out
-of-pocket spending. Conversely, per 
capita spending on generic prescrip-
tions increased from 2012 to 2013 by 
$9, but fell by $16 between 2013 and 
2014. 
In 2014, out-of-pocket spending on 
brand prescriptions was $297 per 
capita or 47.2% of out-of-pocket 
spending per capita on all prescrip-
tions (Table 2). Of the out-of-pocket 
spending on brand prescriptions, the 
largest share (22.7%) was on brand 
anti-diabetic agents ($143 per capita; 
Appendix Table A20). The only other 
detailed category that had higher out-
of-pocket spending was visits to the 
doctor. After brand anti-diabetic 
agents, insureds with diabetes spent 
the most brand prescription out-of-
pocket dollars on brand cardiovascu-
lar drugs ($55 per capita). The decline 
in out-of-pocket spending over the 
study period on brand prescriptions 
was driven largely by declining out-of
-pocket spending on cardiovascular 
drugs. Out-of-pocket spending on 
brand cardiovascular drugs fell every 
year of the study period, declining by 
a total of $37 dollars between 2012 
and 2014. 
In 2014, $331 per capita was spent 
out of pocket on generic prescrip-
tions, which made up 52.6% of out-of-
pocket spending on all prescriptions 
(Table 2). Of this amount, the most 
was spent on generic cardiovascular 
drugs ($96 per capita), followed by 
generic central nervous system (CNS) 
agents ($58), and generic anti-
diabetic agents ($39; Appendix Table 
A20). Total out-of-pocket spending on 
generic prescriptions rose between 
2012 and 2013 due to  a small in-
crease in out-of-pocket spending on 
anti-diabetic agents ($5 per capita 
increase). However, from 2013 to 
2014, a decline in out-of-pocket 
spending on generic cardiovascular 
drugs ($5 per capita decrease) and 
anti-diabetic agents ($6 per capita 
decrease) drove declining total out-of
-pocket spending on generic prescrip-
tions.  
Outpatient Out-of-Pocket 
In 2014, out-of-pocket spending per 
capita on outpatient services was 
$500 (Table 2). These dollars were 
almost evenly divided between outpa-
tient visits ($253 per capita) and out-
patient-other services ($248). Overall 
out-of-pocket spending on all health 
services grew from 2013 to 2014 be-
cause of an increase in out-of-pocket 
spending on outpatient services. Be-
tween 2013 and 2014, out-of-pocket 
spending on outpatient visits rose 
$17, and rose by $18 on outpatient-
other services. 
In 2014, outpatient visits accounted 
for 50.6% ($253 per capita) of the out
-of-pocket spending on outpatient 
services (Table 2). Of the out-of-
pocket dollars spent on outpatient 
visits, spending was highest on outpa-
tient surgical visits ($132 per capita), 
followed by ER visits ($111), and ob-
servation ($9; Appendix Table A20). 
The $39 growth in out-of-pocket 
spending on outpatient visits over the 
study period was largely the result of 
rising out-of-pocket spending on ER 
visits. From 2012 to 2013, out-of-
pocket spending on ER visits grew by 
$13 per capita (59.1% of the total 
increase in outpatient visit spending). 
And from 2013 to 2014, it grew by an 
additional $14 dollars per capita 
(82.4% of the total increase in outpa-
tient visit spending).  
In 2014, outpatient-other services 
accounted for 49.6% ($248 per capi-
ta) of out-of-pocket spending on all 
outpatient services (Table 2). Of these 
dollars, out-of-pocket spending was 
highest for ancillary services ($77 per 
capita), followed by outpatient radiol-
ogy services ($65; Appendix Table 
A20). Out-of-pocket spending on an-
cillary services grew the most of any 
outpatient-other detailed category 
over the study period. From 2012 to 
2013, out-of-pocket spending on an-
cillary services grew by $5 per capita, 
and from 2013 to 2014 it grew by an 
additional $5. 
Acute Inpatient Out-of-Pocket 
Out-of-pocket spending per capita on 
acute inpatient admissions was the 
lowest spending for any service cate-
gory over the study period. Out-of-
pocket spending on acute inpatient 
admissions was $128 per capita in 
2014 (Table 2). Of the dollars spent 
out-of-pocket on inpatient admissions 
in 2014, the most were spent on med-
ical admissions ($71 per capita; Ap-
pendix Table A20). After medical ad-
missions, out-of-pocket spending was 
highest on surgical admissions ($47 
per capita). Out-of-pocket per capita 
spending on acute admissions fell by 
$6 between 2013 and 2014. This de-
cline was largely the result of falling 
out-of-pocket spending on medical 
admissions (fell by $3 per capita) and 
surgical admissions (fell by $3). 
Out-of-Pocket Spending by Gender 
As with the total health care spending 
per capita trends, women spent more 
Per capita out-of-pocket spending on brand prescriptions was 6 
times higher for people with diabetes than for those without dia-
betes (Table 2 and Appendix Table A19). 
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OUT-OF-POCKET SPENDING ACCOUNTED FOR A SMALLER SHARE OF TOTAL SPENDING FOR THOSE WITH DIA-
BETES  
Each year of the study period, insureds with diabetes spent, per capita, two and half times more out-of-pocket than insureds 
without diabetes (Table 2 and Appendix Table A19). For example, in 2014, insureds with diabetes spent $1,944 per capita 
out of pocket, compared to $752 per capita spent out of pocket by insureds without diabetes (Figure 5). However, the share 
of spending paid out of pocket by those with diabetes was smaller than the share of total spending by those without diabetes. 
In 2014, for those with diabetes, out-of-pocket spending accounted for 12.1% of total per capita spending (payer spending 
plus out-of-pocket spending), compared with 17.1% for those without diabetes (Appendix Table A19), but of a much larger 
total dollar amount (Table 2). These trends were also observed in 2012 and 2013.  
 
For both groups, those with and without diabetes, the largest share of their out-of-pocket spending was on professional ser-
vices. For people with diabetes, in 2014, 35.2% of their out-of-pocket spending was on professional services, while for people 
without diabetes this share was 46.4%.  Of the detailed categories of professional services, the most out-of-pocket spending 
for both populations was on visits to the doctor: $217 per person with diabetes and $108 per person without diabetes
(Appendix Tables A20 and A21). Proportionally, this spending was nearly even across the two groups. Visits to the doctor 
made up 31.7% of the spending of professional services for people with diabetes, compared with 30.9% of the professional 
spending for people without diabetes.  
As a share of total spending, out-of-pocket spending on outpatient services for people with and without diabetes was similar 
(25.7% and 28.5%, respectively; Appendix Tables A2 and A19). However, the types of outpatient services on which they 
spent their dollars differed between the two populations. Nearly 60% of out-of-pocket outpatient spending for people with-
out diabetes was on ER visits and outpatient surgical visits. In contrast, less than 50% of the outpatient spending for people 
with diabetes was on ER visits and outpatient surgical visits. Also, per capita out-of-pocket spending for people with diabetes 
on outpatient ancillary services was 15.4%, compared with 6.5% for people without diabetes.  
$1,868
$1,934 $1,944
$709 $733 $752
 
2012 2013 2014
 
Diabetes No Diabetes
Source: HCCI, 2016.
Notes: All data weighted to reflect the national, younger than 65 ESI population.
Data from 2012 and 2013 actuarially completed.
Out-of-Pocket Spending Per Capita for Insureds
With and Without Diabetes: 2012-2014
Figure 5
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out of pocket per capita than did men 
in every year of the study period. For 
example, in 2014 women spent 
$2,060 out of pocket, while men spent 
$1,845 out-of-pocket (Table 2). Over 
the study period, out-of-pocket 
spending for women grew by more 
dollars (rose by $81 per woman) than 
out-of-pocket spending for men (rose 
by $75 per man).  
Women had higher out-of-pocket per 
capita spending on every service cate-
gory than did men. In 2014, the larg-
est differences between men and 
women’s out-of-pocket spending 
were observed for professional ser-
vices (a $122 per capita difference) 
and outpatient services (a $85 differ-
ence; Appendix Table A22). For both 
men and women, more out-of-pocket 
per capita dollars went to profession-
al services than any other service cat-
egory. Per capita out-of-pocket spend-
ing on professional services was $750 
per woman and $628 per man, a $122 
difference. Over the study period, out-
of-pocket spending per capita on both 
professional and outpatient services 
rose for both men and women. For 
men, out-of-pocket spending rose by 
$58 per man on professional services 
and $70 on outpatient services. For 
women, out-of-pocket spending rose 
by $63 per woman on professional 
services and $78 on outpatient ser-
vices. 
Out-of-pocket per capita spending on 
prescriptions was nearly equal for 
men and women. Spending out of 
pocket on prescriptions was $630 per 
woman and $627 per man in 2014 
(Appendix Table A22). Women only 
out spent men by $3 per capita on 
prescriptions. This was also true for 
out-of-pocket spending on generic 
prescriptions, where women out 
spent men by $33 per capita. Howev-
er, per capita out-of-pocket spending 
for men on brand prescriptions was 
higher than this spending for women. 
In 2014, men spent $311 per capita 
out of pocket on brand prescriptions, 
while women spent $280. For both 
men and women, out-of-pocket 
spending on brand prescriptions de-
clined across the study period. Be-
tween 2012 and 2014, spending out 
of pocket for men fell by $54 per man 
and by $52 per woman. Conversely, 
out-of-pocket per capita spending on 
generic prescriptions rose for both 
men and women rose between 2012 
and 2013, by $10 per man and $8 per 
woman. However, this out-of-pocket 
spending fell the following year by 
$15 per man and $17 per woman. 
Additionally, women’s out-of-pocket 
spending on acute inpatient admis-
sions was quite similar to that by 
men. In 2014, women spent $131 per 
capita on acute admissions while men 
spent $126, $5 difference (Appendix 
Table A22). Similar to the trends for 
out-of-pocket spending on generic 
prescriptions, spending on acute ad-
missions rose for both men and wom-
en between 2012 and 2013. Out-of-
pocket spending on acute admissions 
rose by $10 per man and by $9 per 
woman. The following year, out-of-
pocket spending on acute admissions 
fell for both genders: by $4 per man 
and by $8 per woman.  
Out-of-Pocket Spending by Age 
Group 
In 2014, out-of-pocket per capita 
spending for children was the highest 
for any age group ($2,173; Table 2). 
After children, out-of-pocket per capi-
ta spending was highest for pre-
Medicare adults ($2,046). However, 
2014 was the only year in the study 
period for which spending per capita 
out of pocket for children was higher 
than spending for pre-Medicare 
adults. In 2014, per capita out-of-
pocket spending was higher for chil-
dren than for pre-Medicare adults 
because the spending for children 
increased by 5.7%, while the spend-
ing for pre-Medicare adults declined 
by 1.0%. Out-of-pocket spending per 
capita for children grew by the most 
dollars over the entire study period 
($256 per child), while out-of-pocket 
spending grew the least for pre-
Medicare adults ($38 per adult).  
In every year of the study period, the 
lowest per capita out-of-pocket 
spending was by intermediate adults 
(Table 2). In 2014, intermediate 
adults spent $1,791 per capita out of 
pocket. This was followed by out-of-
pocket per capita spending for young 
adults ($1,850) and middle-age adults 
($1,869). As with spending for chil-
dren, per capita out-of-pocket spend-
ing for these three age groups in-
creased in every year studied.  
Children 
Out-of-pocket spending per capita for 
children in 2014 was $2,173, the 
highest of any age group (Table 2). In 
2012 and 2013, children had the sec-
ond highest per capita spending after 
pre-Medicare adults. Out-of-pocket 
spending grew over the study period 
for children, rising $139 from 2012 to 
2013 and by an additional $117 from 
2013 to 2014.  
Of the dollars spent out of pocket for 
children in 2014, the most were spent 
on prescriptions ($751 per child; Ap-
pendix Table A24). This was the high-
est per capita out-of-pocket spending 
on any service category by any age 
group. Children were the only age 
group for whom out-of-pocket per 
capita spending on prescriptions in-
creased in 2014. For all of the other 
age groups, this out-of-pocket spend-
ing declined by at least 3%. The in-
crease for children was due an in-
crease in out-of-pocket per capita 
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spending on brand prescriptions, 
which increased by $38 per capita to 
$433. The most prescription out-of-
pocket dollars for children were spent 
on brand antidiabetic agents ($350 
per child; Appendix Table A26). After 
prescriptions, out-of-pocket spending 
per capita for children was highest on 
outpatient services ($703), followed 
by professional services ($522), and 
acute inpatient admissions ($196; 
Appendix Table A24). After spending 
on brand antidiabetic agents, the 
most out-of-pocket dollars for chil-
dren were spent on outpatient ancil-
lary services ($395 per child) and 
visits to the doctor ($228 per child; 
Appendix Table A26). 
Young Adults 
Out-of-pocket per capita spending for 
young adults in 2014 was $1,850 
(Table 2). This was the second lowest 
per capita out-of-pocket spending for 
any age group. In terms of dollars, out
-of-pocket spending by young adults 
grew the second most after out-of-
pocket spending for children over the 
study period. From 2012 to 2013 out-
of-pocket spending by young adults 
grew by $103 per capita, and rose by 
an additional $66 from 2013 to 2014. 
Of the dollars spent out-of-pocket, the 
most were spent on outpatient ser-
vices ($615 per young adult; Appen-
dix Table A24 and Figure 6). The most 
outpatient out-of-pocket dollars were 
spent on ancillary services ($228 per 
young adult) and ER visits ($202 per 
young adult; Appendix Table A28). 
After outpatient services, the most 
out-of-pocket per capita dollars were 
spent on professional services ($539), 
prescriptions ($478), and acute inpa-
tient admissions ($216; Appendix 
Table A24).  
Unlike all of the other age groups, the 
per capita out-out-pocket spending by 
young adults on brand and generic 
prescriptions declined each year stud-
ied (Appendix Table A24). Total out-
of-pocket spending on prescriptions 
declined from $506 per young adult 
in 2012 to $478 in 2014. The most out
-of-pocket dollars on prescriptions 
were spent on brand antidiabetic 
agents ($230 per capita in 2014), a 
slight increase over the study period 
(by $7 per capita; Appendix Table 
A28). Compared to the other age 
groups, young adults had higher per 
capita spending on acute inpatient 
admissions in each year of the study 
period (Appendix Table A24).  
Intermediate Adults 
Out-of-pocket per capita spending for 
intermediate adults was the lowest of 
any age group in all years studied. In 
2014, out-of-pocket spending was 
$1,791 per intermediate adult (Table 
2). Out-of-pocket spending rose over 
the study period, increasing more 
from 2012 to 2013 ($85 per capita), 
than from 2013 to 2014 ($61). Unlike 
the younger age groups, intermediate 
adults spent the most per capita on 
professional services ($648 in 2014; 
Appendix Table A24 and Figure 6). 
The most out-of-pocket dollars on 
professional services were spent on 
visits to the doctor: $203 per interme-
diate adult in 2014 (Appendix Table 
A30).  
After professional services, the most 
out-of-pocket dollars were for outpa-
tient services ($532 per capita; Ap-
pendix Table A24 and Figure 6). Un-
like all of the other age groups, the 
most outpatient out-of-pocket dollars 
spent by intermediate adults were on 
ER visits. In 2014, out-of-pocket 
spending on ER visits was $172 per 
intermediate adult (Appendix Table 
A30). Out-of-pocket spending on out-
patient services generally, and ER 
visits specifically, saw high growth 
over the study period. Between 2012 
and 2014, out-of-pocket spending on 
outpatient services grew $91 per cap-
ita and grew $44 on ER visits 
(Appendix Tables A24 and A30). This 
growth in out-of-pocket spending was 
an important driver in total out-of-
pocket spending growth for interme-
diate adults over the study period.  
The least out-of-pocket dollars for 
intermediate adults were on prescrip-
tions ($464 per capita), and acute 
inpatient admissions ($146; Appendix 
Table A24). As with the other adult 
age groups, out-of-pocket spending 
on prescriptions fell over the study 
period, driven by declining out-of-
pocket spending on brand prescrip-
tions.  
Middle-Age Adults 
In 2014, middle-age adults spent 
$1,869 out of pocket per capita (Table 
2). Compared to out-of-pocket spend-
ing per capita trends for the other age 
groups, spending out of pocket by 
middle-age adults was in the middle. 
For middle-age adults, out-of-pocket 
spending grew more from 2012 to 
Out-of-pocket spending per child was over twice as high on doctor 
visits and ER visits for children with diabetes as compared to chil-
dren without diabetes (Appendix Tables A26 and A27). 
Out-of-pocket spending per young adult on acute inpatient admis-
sions was nearly five times higher for young adults with diabetes 
as those without (Appendix Tables A24 and A25).  
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2013 ($61 per capita), than from 
2013 to 2014 ($20).  
In 2014, middle-aged adults spent the 
most of their per capita out-of-pocket 
dollars on professional services 
($666), followed by prescriptions 
($594), outpatient services ($488), 
and acute inpatient admissions ($119; 
Appendix Table A24 and Figure 
6).Compared to the other age groups, 
middle-age adults had the lowest out-
of-pocket spending on acute admis-
sion during the study period. Within 
these service categories, the most out-
of-pocket dollars were spent on visits 
to the doctor ($211 per capita), brand 
antidiabetic agents ($133 per capita), 
and outpatient surgical visits ($129 
per capita; Appendix Table A32). As 
was observed for intermediate and 
pre-Medicare adults, falling spending 
out of pocket on brand prescriptions 
drove the decline in out-of-pocket 
spending on all prescriptions for mid-
dle-age adults over the study period 
(Appendix Table A24).  
Pre-Medicare Adults 
In 2014, after children, pre-Medicare 
adults spent the most out of pocket 
per capita ($2,046; Table 2). In the 
two previous years, pre-Medicare 
adults had the highest spending of 
any age group. Pre-Medicare adults 
had just the second highest out-of-
pocket per capita spending in 2014 
because it fell by $20 from 2013 to 
2014. Over the entire study period, 
out-of-pocket spending for Pre-
Medicare adults grew by the least 
dollars of any age group. Between 
2012 and 2014, out-of-pocket spend-
ing increased by $38 per pre-
Medicare adult.  
Pre-Medicare adults spent the most 
out-of-pocket per capita on profes-
sional services ($720 in 2014), fol-
lowed by prescriptions ($712), outpa-
tient services ($487), and acute inpa-
tient admissions ($122; Appendix 
Table A24 and Figure 6). Compared to 
the other age groups, pre-Medicare 
adults had the highest per capita out-
of-pocket spending on professional 
services. In contrast, pre-Medicare 
adults had the lowest out-of-pocket 
spending per capita on outpatient 
services, and comparatively low 
spending on acute admissions. For 
pre-Medicare adults, the most out-of-
pocket per capita dollars were spent 
on visits to the doctor ($227 per pre-
Medicare adult), outpatient surgical 
visits ($147), and brand antidiabetic 
agents ($143; Appendix Table A33). 
The ratio of out-of-pocket spending for people with diabetes to 
those without diabetes declined with age. The difference in spend-
ing between people with and without diabetes was largest for chil-
dren (4.7) and smallest for pre-Medicare adults (1.7; Table 2 and 
Appendix Table A21). 
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Utilization of Health Services for Insureds with 
Diabetes 
For people with diabetes, utilization 
of most medical subservice categories 
declined over the 2012-2014 study 
period (Table 3 and Figure 7). The 
number of acute inpatient admissions, 
outpatient-other services, and profes-
sional services declined every year 
studied. Only use of outpatient visits 
increased slightly between 2012 and 
2014 (by 9 visits per 1,000 people). 
Additionally, the use of filled days of 
brand prescriptions declined over the 
study period (Table 3). At the same 
time, the use of generics increased 
each year. This increase was larger 
than the decline in use of brand pre-
scriptions, leading to a net increase in 
the use of prescriptions between 
2012 and 2014. 
Use of Professional Services  
In each year of the study period, the 
most services used by people with 
diabetes were professional services. 
In 2014, there were 36,927 profes-
sional services per 1,000 people 
(Table 3). This number declined 
slightly each year studied. Between 
2012 and 2014, the number of profes-
sional services declined by 607 ser-
vices per 1,000 people.  
Of the types of professional services, 
the one with the highest rate of use 
was professional laboratory and pa-
thology services (lab/path). In 2014, 
there were 13,193 lab/path services 
per 1,000 people. The use of lab/path 
services increased slightly between 
2012 and 2013 (by 122 services per 
1,000), before declining slightly the 
following year (by 63 services per 
1,000; Appendix Table A37). Another 
frequently used service for people 
with diabetes was visits to the doctor. 
In 2014, there were 6,692 doctor vis-
its per 1,000 people. The number of 
visits increased slightly in 2013 (by 
84 visits per 1,000), and declined 
slightly the following year (by 84 vis-
its per 1,000).   
Use of Outpatient  
The second-highest medical service 
category used was outpatient ser-
vices. In 2014, there were 9,085 out-
patient services per 1,000 people 
(Table 3). Use of outpatient services 
declined over the study period, from 
9,423 outpatient services per 1,000 
people 2 to 9,085 services per 1,000 
people.  
Of these outpatient services, the vast 
majority were outpatient-other ser-
vices. In 2014, there were 8,373 out-
patient-other services per 1,000 peo-
ple (Table 3). The use of these ser-
vices fell slightly each year studied. 
The most used type of outpatient-
other service was outpatient labora-
tory and pathology services. In 2014, 
there were 3,458 outpatient lab/path 
services per 1,000 people, falling 
slightly from 3,634 services per 1,000 
people in 2012 (Appendix Table A37). 
Unlike the use of outpatient-other 
services, use of outpatient visits in-
creased slightly over the study period. 
Use increased by 1 visit per 1,000 
people in 2013 and by an additional 8 
visits the following year (to 712 visits 
Individuals without diabetes had half the number of doctor visits 
and half as many ER visits compared to people with diabetes 
(Appendix Tables A37 and A38).  
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per 1,000 people; Table 3). Use of out-
patient visits was split fairly evenly 
between ER visits and outpatient sur-
gery visits. In 2014, there were 329 
ER visits per 1,000 people and 314 
outpatient surgery visits (Appendix 
Table A37). In comparison, there 
were just 69 observation visits per 
1,000 people.  
Use of Acute Inpatient 
Of the medical subservice categories 
in 2014, acute inpatient admissions 
had the lowest use rate (160 acute 
admissions per 1,000 people; Table 
3). There was a small decline in the 
use of acute admissions over the 
study period. The number of admis-
sions declined by 7 admissions per 
1,000 people between 2012 and 
2013, and by an additional 3 admis-
sions the following year. Medical ad-
missions were the most common for 
people with diabetes. In 2014, there 
were 95 medical admissions per 
1,000 people, nearly twice as many as 
the number of surgical admissions 
(55 admissions per 1,000; Appendix 
Table A37).  
 
Use of Prescriptions 
In 2014, people with diabetes used 
1,242,571 filled days of prescriptions 
per 1,000 people (Table 3). This pre-
scription use rate averages to just 
over 3 drugs per person with diabetes 
per day. Over 80% of these filled days 
of prescriptions were generic. The use 
of generic prescriptions increased 
each year studied. Use increased by 
94,244 filled days per 1,000 people, 
from 933,587 days in 2012 to 
1,027,831 in 2014. At the same time, 
the use of brand prescriptions de-
clined by 54,537 filled days per 1,000 
people, from 268,738 filled days in 
2012 to 214,201 filled days in 2014.   
The most used therapeutic class of 
prescriptions in 2014 was generic 
cardiovascular drugs. Use of this class 
of prescriptions increased over the 
study period by about 5% per year, to 
368,607 filled days per 1,000 people 
in 2014 (Appendix Table A37 and 
Figure 8). The second most used class 
of prescriptions was generic antidia-
betic agents (171,919 filled days per 
1,000 people in 2014), followed by 
brand antidiabetic agents (107,570 
filled days). Combined, brand and 
generic antidiabetic agents accounted 
for 22.5% of total prescription use by 
people with diabetes. Use of generic 
antidiabetic agents increased each 
year studied, by 17,013 filled days 
between 2012 and 2014. Use of brand 
antidiabetic agents, however, de-
clined between 2012 and 2013 (by 
8,705 filled days), before increasing in 
2014 (by 2,170 filled days).  
Use by Gender 
For all the medical subservice catego-
ries, use of services per 1,000 women 
was higher than use by men 
(Appendix Table A39). This difference 
in service use, expressed as a ratio of 
services used by women to use by 
men, was largest for outpatient visits 
(1.3) and smallest for acute inpatient 
admissions (1.1). Use of filled days of 
generic prescriptions per 1,000 peo-
ple was also slightly higher for wom-
en than men (1.06). Only for filled 
days of brand prescriptions was use 
higher for men than for women 
(0.92).  
For women with diabetes, the medical 
subservice category with the highest 
use was professional services. In 
2014, there were 41,038 professional 
services per 1,000 women (Appendix 
Table A39). Between 2012 and 2014, 
a small decline occurred in the rate of 
Compared to people without diabetes, people with diabetes used 5 
times more filled days of generic prescriptions and 7 times more 
filled days of brand prescriptions (Table 3 and Appendix Table 
A36).  
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use of these services: by 833 services 
per 1,000 women. A small year-on-
year decline also occurred in the use 
of acute inpatient admissions.  
The number of admissions declined 
by 12 admits per 1,000 women, from 
182 admissions in 2012 to 170 in 
2014. Similarly, use of outpatient-
other services also declined each year 
studied, from 9,297 services per 
1,000 women in 2012 to 8,882 in 
2014. While use of outpatient visits 
declined slightly between 2012 and 
2013 – from 805 visits per 1,000 
women to 801 visits, a small increase 
occurred in use of visits in 2014 (to 
812 visits per 1,000).  
In 2013, the use of filled days of brand 
prescriptions declined by 13.8% and 
by an additional 7.9% in 2014. This 
was a decline of 52,942 filled days of 
brand prescriptions over the study 
period. However, the use of filled days 
of generic prescriptions increased 
every year studied. This increase in 
generic filled days of 91,918 filled 
days of generic prescriptions per 
1,000 women led to a net increase in 
the total filled days of prescriptions 
over the study period. Total filled 
COMPARISON OF THE RATES OF SERVICE USE FOR PEOPLE WITH AND WITHOUT DIABETES  
In every year of the study period, people with diabetes had higher rates of use for all of the service categories compared to 
people without diabetes (Table 3 and Appendix Table A36). Across the service categories, the difference in use between the 
two groups was larger for some categories of services than for others. When examining the ratio of service use for people 
with diabetes compared to those without, the ratio is largest for brand prescriptions (7.1) and generic prescriptions (5.1) 
and smallest for professional services (2.4; Figure 9). In other words there is a larger difference in use of prescriptions than 
of professional services. In 2014, people with diabetes used 1,242,571 filled days of prescriptions, compared to 233,208 filled 
days for people without diabetes (Table 3 and Appendix Table A36). 
 
For prescriptions, this difference in use was due largely to the use of antidiabetic agents by people with diabetes (279,489 
filled days of antidiabetic agents per 1,000 people with diabetes). The difference was also influenced by the comparatively 
higher use of cardiovascular agents by people with diabetes. In 2014, there were 414,524 filled days of cardiovascular agents 
per 1,000 people with diabetes compared to 55,291 filled days of cardiovascular agents per 1,000 people without diabetes. 
After brand and generic prescriptions, the next highest use ratio – the second-largest difference in rate of service use – in 
2014 was observed for outpatient other services (3.8). Within the outpatient services category, the biggest difference in use 
between people with diabetes and those without was for ancillary services (6.0). In 2014, there were 1,980 ancillary services 
per 1,000 people with diabetes compared to 328 ancillary services per 1,000 people without diabetes.   
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days of prescriptions increased from 
1,227,220 filled days per 1,000 wom-
en in 2012 to 1,266,384 filled days in 
2014.  
As with women, the medical sub-
service category with highest use by 
men was professional services. In 
2014, there were 33,387 professional 
services per 1,000 men (Appendix 
Table A39). The number of profes-
sional services increased slightly be-
tween 2012 and 2013 (by 80 services 
per 1,000 men), before a small decline 
in use the following year (by 442 ser-
vices per 1,000 men). The use of acute 
inpatient admissions declined in eve-
ry year studied, from 159 admissions 
per 1,000 men in 2012 to 152 in 
2014. A year-on-year decline of 1.5% 
also occurred in use of outpatient-
other services. Use of outpatient-
other services declined about 1.5% 
each year, from 8,215 services per 
1,000 men in 2012 to 7,935 in 2014. 
Conversely, use of outpatient visits 
increased by about 1.0% per year 
across the study period, from 11 visits 
to 626 visits. Similarly, use of filled 
days of generic prescriptions in-
creased each year studied, by 96,544 
filled days per 1,000 men between 
2012 and 2014. This increase more 
than offset the decline of 56,008 in 
filled days of brand prescriptions dur-
ing the same period.  
Use by Age Group 
Children 
Children (ages 0-18) with diabetes 
had a higher use rate of outpatient 
services compared to the other age 
groups. In 2014, there were 11,138 
outpatient services per 1,000 children 
(Appendix Table A41). This high use 
of outpatient services was driven by 
the use of outpatient-other services 
(10,561 per 1,000 children), which 
accounted for 94.8% of outpatient 
service use. In contrast, children had 
the lowest rate of outpatient visit use 
(Figure 10). In 2014, there were 577 
outpatient visits per 1,000 children, 
which was 56% lower than the use of 
outpatient visits by young adults (the 
age group with the highest use). Of 
these outpatient visits for children, 
75.9% were ER visits (438 visits per 
1,000 children; Appendix Table A43). 
Children also had the lowest use of 
professional services. In 2014, there 
were 25,646 professional services per 
1,000 children a slight decline over 
the previous year (Appendix Table 
A41). Of these professional services, 
24.4% were visits to the doctor 
(6,249 doctor visits per 1,000 chil-
dren) and 31.0% were lab/path pro-
fessional services (7,943 services per 
1,000 children; Appendix Table A43). 
Use of acute admissions per 1,000 
children declined every year studied, 
from 200 admissions to 195 admis-
sions (Appendix Table A41). This de-
cline was due largely to a small de-
cline over the study period in the use 
of medical admissions. The number of 
medical admissions declined from 
168 admissions per 1,000 children in 
2012 to 160 admissions in 2014 
(Appendix Table A43). 
Children were the only age group for 
whom increases occurred in the num-
ber of filled days of brand prescrip-
tions during the study period. Be-
tween 2012 and 2014, the number of 
filled days of brand prescriptions rose 
by 12,022 filled days per 1,000 chil-
dren (Appendix Table A41). Due to 
this increase in use, by 2014, children 
had higher rates of use of brand pre-
scriptions than any other age groups. 
Brand prescriptions also constituted a 
larger proportion of total prescrip-
tions (40.0%) than for any other age 
group. This high use of brand pre-
scriptions was driven largely by the 
use of brand antidiabetic agents. Chil-
There were 3 times as many acute admissions for women with dia-
betes compared to women without diabetes, and 4 times as many 
acute admissions for men with diabetes compared to men without 
diabetes (Appendix Tables A39 and A40). 
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dren used more filled days of brand 
antidiabetic agents per 1,000 people 
then did any other age group 
(Appendix Table A43 and Figure 11). 
And this use increased each year 
studied. In 2014, there were 255,481 
filled days of brand antidiabetic 
agents per 1,000 children. In compari-
son, children used 1.5 times more of 
these prescriptions than did young 
adults, who had the second highest 
use (172,369 filled days of brand anti-
diabetic agents per 1,000 young 
adults; Appendix Table A45).     
Young Adults 
Young adults (19-25) with diabetes 
were the only age group to see an in-
crease in service use for all the medi-
cal subservice categories in each 
study year. Young adults also had 
more acute hospital admissions per 
1,000 people than the other age 
groups (Appendix Table A41). In 
2014, there were 259 acute admis-
sions per 1,000 young adults. Acute 
admissions rose from 247 admits per 
1,000 in 2012 to 259 in 2014, a 5% 
increase. In comparison, the next 
highest use of acute admissions was 
for children, who had 195 admissions 
per 1,000 children in 2014. For young 
adults, the most admissions in 2014 
were medical (172 admissions per 
1,000), followed by MH/SU admis-
sions (37 admissions), and LD admis-
sions (28 admissions; Appendix Table 
A45). 
Young adults also had a higher rate of 
outpatient visit use compared to the 
other age groups (Appendix Table 
A41 and Figure 10). In 2014, there 
were 902 outpatient visits per 1,000 
young adults, an increase of 24 visits 
over 2012. Of these outpatient visits, 
80.4% were ER visits (725 visits per 
1,000 young adults in 2014; Appendix 
Table A45), which was the highest 
rate of ER visit use among the five age 
groups. As with the other age groups, 
young adults’ most used subservice 
category was professional services 
(30,289 professional services per 
1,000 young adults; Appendix Table 
A41). Of these professional services, 
17.5% were visits to the doctor 
(5,287 doctor visits per 1,000 young 
adults), while 41.9% were lab/path 
professional services (12,686 per 
1,000 young adults; Appendix Table 
A45). At the same time, compared to 
the other age groups, young adults 
had lower use of filled days of pre-
scriptions (592,734 filled days per 
1,000 young adults; Appendix Table 
A41). 
Intermediate Adults 
For intermediate adults (ages 26-44), 
the rates of use of the medical sub-
service categories declined between 
2012 and 2013. The following year, 
use of acute inpatient admissions, 
outpatient visits, and professional 
services increased slightly (Appendix 
Table A41). Compared to the other 
age groups, intermediate adults had a 
low rate of use of acute inpatient ad-
missions. In 2014, there were 154 
acute admissions per 1,000 interme-
diate adults. The majority of these 
admissions were medical admissions 
(82 admissions per 1,000 intermedi-
ate adults) followed by LD admissions 
(25 admissions per 1,000 intermedi-
ate adults; Appendix Table A47). 
Compared to the other age groups, 
intermediate adults had the lowest 
rate of use for outpatient services 
(7,383 services per 1,000 intermedi-
ate adults) (Appendix Table A41). 
This low use was due largely to com-
paratively low use of outpatient-other 
services. In 2014, there were 6,643 
outpatient-other services per 1,000 
working age adults (Appendix Table 
A41).  
However, working adults had the sec-
ond highest (after young adults) use 
of outpatient visits: 740 visits per 
1,000 intermediate adults (Figure 10). 
Of those visits, 65.3% were ER visits 
(483 ER visits per 1,000 intermediate 
adults) and 26.8% were outpatient 
surgical visits (198 visits; Appendix 
Table A47).  Between 2013 and 2014, 
the use of professional services by 
intermediate adults increased slight-
ly, to 32,948 professional services per 
1,000 adults (Appendix Table A41). 
The most used type of professional 
service was lab/path services (12,883 
professional lab/path services per 
1,000 intermediate adults) followed 
by visits to the doctor (6,023 visits 
per 1,000; Appendix Table A47).  
Compared to the other age groups, 
intermediate adults had the lowest 
use of brand prescriptions. In 2014, 
there were 152,127 filled days of 
brand prescriptions per 1,000 inter-
mediate adults (Appendix Table A41). 
As with the other age groups, the larg-
est proportion of brand prescriptions 
was filled days of brand antidiabetic 
agents. However, intermediate adults 
had the lowest rate of use of filled 
days of brand antidiabetic agents 
(96,730 filled days per 1,000 interme-
diate adults) of the five age groups 
(Appendix Table A47 and Figure 11). 
Brand prescriptions made up 18.6% 
of total prescription use by intermedi-
ate adults (Appendix Table A41). The 
total number of filled days of pre-
scriptions increased each year during 
Young adults with diabetes had 4 times more mental health and 
substance use admissions and nearly 3.5 times more ER visits than 
young adults without diabetes (Appendix Tables A45 and A46).  
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the study period. This was the only 
adult age group from which a year-on
-year increase occurred in total pre-
scription use.  
Middle-Age Adults 
We observed general declines in the 
rates of use of the medical subservice 
categories by middle-age adults. The 
only increase in use of services for 
this age group occurred between 
2013 and 2014 in the rate of use of 
outpatient visits per 1,000 (from 677 
visits to 687 visits; Appendix Table 
A41). This increase was due to an in-
crease in the rate of use of ER visits 
per 1,000 between 2013 and 2014 – 
from 316 visits to 330 visits 
(Appendix Table A49 and Figure 11). 
The rates of use of acute inpatient 
admissions, outpatient-other services, 
and professional services all declined 
in each year studied (Appendix Table 
A41). Interestingly, in 2014, middle-
age adults had the lowest number of 
acute admissions: 141 per 1,000 mid-
dle-age adults. As with intermediate 
adults, the number of filled days of 
prescriptions per 1,000 middle-age 
adults increased each year of the 
study period. This was due to an in-
crease in the number of filled days of 
generic prescriptions between 2012 
and 2014, which rose from 879,274 
filled days of generic prescriptions to 
974,063 filled days.  
Pre-Medicare Adults 
The rates of use of the medical sub-
service categories by pre-Medicare 
adults (ages 55-64) generally de-
clined across the study period. Only 
use of outpatient visits saw small in-
creases in the years studied 
(Appendix Table A41). Similar to 
young adults, total prescription use 
declined slightly between 2012 and 
2013 before increasing the following 
year. Use of professional services by 
pre-Medicare adults declined over the 
study period. At the same time, use of 
professional services, in general, in-
creased with age. Pre-Medicare adults 
used more professional services per 
1,000 people than the other age 
groups. In 2014, there were 39,917 
professional services per 1,000 pre-
Medicare adults. The most used type 
of professional service was lab/path 
services: 13,632 professional lab/
path services per 1,000 pre-Medicare 
adults (Appendix Table A51). There 
were also 7,163 visits to the doctor 
per 1,000 adults. Similar to middle-
age adults, there were small declines 
in the use of acute inpatient admis-
sions and outpatient-other services 
over the study period (Appendix Ta-
ble A41). The number of acute admis-
sions declined from 181 admits per 
1,000 pre-Medicare adults in 2012 to 
171 in 2014.  
The number of outpatient-other ser-
vices declined from 9,890 per 1,000 
pre-Medicare adults in 2012 to 9,383 
in 2014 (Appendix Table A41). Con-
versely, pre-Medicare adults’ use of 
outpatient visits increased every year 
studied. Between 2012 and 2014, out-
patient visits per 1,000 pre-Medicare 
adults rose from 710 visits to 719 
visits. Unlike the other age groups, 
outpatient surgical visits were the 
most common type of outpatient visit 
for pre-Medicare adults (Appendix 
Table A51 and Figure 11). In 2014, 
there were 381 outpatient surgical 
visits per 1,000 and 258 ER visits per 
1,000. Pre-Medicare adults used more 
filled days of prescriptions per 1,000 
people than did the other age groups. 
In 2014, there were 1,486,253 filled 
days of prescriptions per 1,000 pre-
Medicare adults (Appendix Table 
A41). Of these filled days, 83.4% were 
generics (1,238,539 filled days) and 
16.6% were brand (247,031) – the 
smallest proportion of brand filled 
days for any age group. For pre-
Medicare adults in 2014, the most 
filled days were for generic cardiovas-
cular agents (474,413 filled days per 
1,000 pre-Medicare adults), followed 
by generic antidiabetic agents 
(201,236 filled days; Appendix Table 
A51 and Figure 10). 
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Data  
HCCI’s dataset contains several billion 
de-identified commercial health in-
surance claims for the years 2010 
through 2014. Three major health 
insurers contributed data to HCCI for 
the purposes of producing a national, 
multipayer, commercial health care 
claims database. These data include 
claims for individuals covered by 
group insurance (fully insured and 
administrative services only), individ-
ual insurance, and Medicare Ad-
vantage plans. The claims data in-
clude prices paid to providers by both 
insurers and insureds and details 
about the services used. Furthermore, 
HCCI’s claims data are compliant with 
the Health Insurance Portability and 
Accountability Act (HIPAA).  
For 2014 Diabetes Health Care Cost 
and Utilization Report, HCCI per-
formed analysis on a subset of data 
for approximately 40 million insureds 
per year (2012–2014). This analytic 
subset consisted of all claims for in-
sureds ages 0 through 64 and covered 
by ESI. The data set used for this re-
port represented about 26% of the 
privately insured people in the United 
States.  
Methods  
HCCI weighed the analytic subset us-
ing United States Census Bureau age-
gender geographic-based estimates of 
the ESI population to make the analyt-
ic subset representative of the nation-
al ESI population. Claims in the ana-
lytic subset from 2013 and 2014 were 
actuarially completed to account for 
claims that had been incurred but not 
adjudicated. HCCI used the weighted, 
actuarially completed dataset to esti-
mate per capita health expenditures, 
average prices, and utilization of ser-
vices for 2012 through 2014. HCCI did 
not correct dollars for inflation; thus, 
all reported expenditures and prices 
were in nominal dollars. 
HCCI analyzed four major categories 
of services, several subservice catego-
ries, and detailed service categories 
(see “Service Categories Analyzed in 
this Report”). Inpatient facility claims 
were from hospitals, skilled nursing 
facilities (SNFs), and hospices where 
detail was sufficient to identify an 
overnight stay by an insured. Outpa-
tient facility claims did not entail an 
overnight stay and included observa-
tion and ER services. Both outpatient 
and inpatient claims consisted of only 
the facility charges associated with 
such claims. Professional services 
(procedures) included claims billed 
by physicians and non-physicians 
according to the industry’s standard 
procedure coding practices. Prescrip-
tion data are prescriptions filled at 
both retail and mail order pharma-
cies.  
For a more detailed description of 
HCCI’s methodology and dataset, see 
the Analytic Methodology on HCCI’s 
Website.5 For a discussion of the cost 
and utilization trends for the national 
younger than 65 ESI population, see 
the 2014 Health Care Cost and Utiliza-
tion Report. Both documents are avail-
able on HCCI’s Website, for details on 
these changes. 
A diagnosis of diabetes was deter-
mined using the DDMT methodology 
for identifying health care activity 
associated with diabetes. Individuals 
with a diagnosis of diabetes for at 
least one inpatient admission, one 
outpatient visit, or two office visits in 
the same calendar year were flagged 
in a year of data as having been diag-
nosed with diabetes (see the HCCI 
Methodology document for a list of 
codes included in this categoriza-
tion).5 Once individuals were flagged 
as having received a diagnosis of dia-
betes, they retained this flag in all 
subsequent years of the dataset. This 
methodology excluded radiology and 
laboratory claims, as these can be 
used for screening purposes and may 
not reflect a diagnosis of diabetes.  
To be flagged in the HCCI dataset as 
having a diagnosis of diabetes, indi-
viduals must have had at least one 
medical claim filed with their insurer 
in one of the years of the study peri-
od. The population of individuals 
without diabetes is composed of all 
members in the HCCI analytic dataset 
who were not flagged as having re-
ceived a diabetes diagnosis. This pop-
ulation without diabetes included 
individuals who never had a medical 
claim filed with their insurer during 
the study period. Therefore, these two 
populations—individuals diagnosed 
with diabetes and individuals without 
diabetes—are similar but not meth-
odologically identical. Per capita 
spending trends and rates of service 
utilization for these populations 
should be treated as estimates. 
Limitations 
This report, like all research, has sev-
eral limitations that affect the gener-
alizability and interpretation of the 
findings. For this reason, HCCI consid-
About the Data and Methodology 
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ers the work a starting point for anal-
ysis and research on individuals cov-
ered by ESI rather than as a conclu-
sive analysis of the ESI population’s 
effect on health care in the United 
States.  
First, our findings were estimates for 
the United States ESI population ages 
0 through 64 based on a sample of 
approximately 26% of these insured 
Americans. Second, the analysis and 
results were descriptive, and the find-
ings were not used to determine caus-
al relationships. The tables and fig-
ures presented are limited to descrip-
tive statistics for individuals covered 
by ESI and younger than age 65. In 
this brief, we presented spending and 
utilization trends for individuals 
flagged as having diagnosed diabetes 
and those not flagged as having diabe-
tes.  
Third, because HCCI’s claims holdings 
reflect only explicit health care activi-
ty, HCCI could not identify individuals 
with diabetes who (1) did not seek 
medical care between 2012 and 2014, 
(2) did not meet our criteria for study 
inclusion, (3) did not file with their 
health insurer a claim that indicated a 
diagnosis of diabetes, or (4) had undi-
agnosed diabetes. Moreover, claims 
data have a mixed record of utility for 
population health studies. Work is 
ongoing to improve the methods used 
to determine health status from ad-
ministrative claims. 
Suggested Citation for This Report:  
“2014 Diabetes Health Care Cost and 
Utilization Report.” Health Care Cost 
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The Impact of Diabetes:  
Costs and Use of Health Care by Children in 2014 
In this report, we estimated that 0.3% of children (ages 0-18) covered by employer-sponsored insurance (ESI) have been 
diagnosed with diabetes. While this might be a relatively small percentage of children, for the kids diagnosed with diabetes 
and their families, this condition can have a big impact. Below we compare the health care costs and service use for the 
average child with diabetes and the average child without diabetes. In 2014, compared to the average child without 
diabetes, the average child with diabetes used more than twice as many health services, and their parents paid more than 4 
times the dollars out of pocket.  
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In 2014, the average child (aged 0-18) with diabetes, compared to the average child without diabetes… 
 
Incurred health care costs that were 6.7 times higher 
Had 2 times as many doctor visits 
Had nearly 5 times more acute inpatient admissions  
Used 4.6 times as many professional laboratory/pathology services 
Had 2.5 times as many ER visits 
Used 10.5 times as many filled days of prescriptions 
Their parents spent:  
4.7 times more out of pocket 
2.4 times more out of pocket on doctor visits  
6.8 times more out of pocket on acute inpatient admissions 
